Novo Nordisk Continues to Limit Supply of Blockbuster Weight-Loss Drug
Novo Nordisk NVO 1.15%increase; green up pointing triangle is gradually expanding supply capacity for its blockbuster weight-loss drug, but said it will continue to limit supply of lower-strength doses of the Wegovy medicine in the U.S. as it seeks to safeguard supplies.